BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22131818)

  • 1. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.
    Trivedi T; Franek BS; Green SL; Kariuki SN; Kumabe M; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
    J Biomed Biotechnol; 2011; 2011():802581. PubMed ID: 22131818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.
    Kariuki SN; Moore JG; Kirou KA; Crow MK; Utset TO; Niewold TB
    Genes Immun; 2009 Jul; 10(5):487-94. PubMed ID: 19339987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
    Lee YH; Song GG
    Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
    Glas J; Seiderer J; Bayrle C; Wetzke M; Fries C; Tillack C; Olszak T; Beigel F; Steib C; Friedrich M; Diegelmann J; Czamara D; Brand S
    PLoS One; 2011; 6(12):e29309. PubMed ID: 22242114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
    D'Alfonso S; Barizzone N; Giordano M; Chiocchetti A; Magnani C; Castelli L; Indelicato M; Giacopelli F; Marchini M; Scorza R; Danieli MG; Cappelli M; Migliaresi S; Bigliardo B; Sabbadini MG; Baldissera E; Galeazzi M; Sebastiani GD; Minisola G; Ravazzolo R; Dianzani U; Momigliano-Richiardi P
    Arthritis Rheum; 2005 Feb; 52(2):539-47. PubMed ID: 15692970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of osteopontin regulatory polymorphisms with systemic sclerosis.
    Barizzone N; Marchini M; Cappiello F; Chiocchetti A; Orilieri E; Ferrante D; Corrado L; Mellone S; Scorza R; Dianzani U; D'Alfonso S
    Hum Immunol; 2011 Oct; 72(10):930-4. PubMed ID: 21763380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction.
    Han S; Guthridge JM; Harley IT; Sestak AL; Kim-Howard X; Kaufman KM; Namjou B; Deshmukh H; Bruner G; Espinoza LR; Gilkeson GS; Harley JB; James JA; Nath SK
    PLoS One; 2008 Mar; 3(3):e0001757. PubMed ID: 18335026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the rs1126616 and rs9138 Variants in the
    Rivera-Cameras A; Gallegos-Arreola MP; Morán-Moguel MC; Salazar-Páramo M; Alcaraz-López MF; Echeverría-González G; Topete-Reyes JF; Franco-Chávez SA; Dávalos-Rodríguez IP
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
    Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
    Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
    Pasha HF; Tantawy EA; Youssef MA
    Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of polymorphisms in the HLA-G 5' upstream regulatory and 3' untranslated regions in Brazilian patients with systemic lupus erythematosus.
    Catamo E; Addobbati C; Segat L; Sotero Fragoso T; Tavares Dantas A; de Ataide Mariz H; Ferreira da Rocha Junior L; Branco PintoDuarte AL; Coelho AV; de Moura RR; Polesello V; Crovella S; Sandrin Garcia P
    Tissue Antigens; 2015 Jun; 85(6):458-65. PubMed ID: 25762019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes.
    Taylor KE; Chung SA; Graham RR; Ortmann WA; Lee AT; Langefeld CD; Jacob CO; Kamboh MI; Alarcón-Riquelme ME; Tsao BP; Moser KL; Gaffney PM; Harley JB; Petri M; Manzi S; Gregersen PK; Behrens TW; Criswell LA
    PLoS Genet; 2011 Feb; 7(2):e1001311. PubMed ID: 21379322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus.
    Löfgren SE; Delgado-Vega AM; Gallant CJ; Sánchez E; Frostegård J; Truedsson L; de Ramón Garrido E; Sabio JM; González-Escribano MF; Pons-Estel BA; D'Alfonso S; Witte T; Lauwerys BR; Endreffy E; Kovács L; Vasconcelos C; Martins da Silva B; Martín J; Alarcón-Riquelme ME; Kozyrev SV
    Arthritis Rheum; 2010 Nov; 62(11):3404-14. PubMed ID: 20669283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Alleles Associated with SLE Susceptibility and Clinical Manifestations in Hispanic Patients from the Dominican Republic.
    Liu Z; Yu Y; Yue Y; Hearth-Holmes M; Lopez PD; Tineo C; Paulino G; Fu WN; Loyo E; Su K
    Curr Mol Med; 2019; 19(3):164-171. PubMed ID: 31032751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD3Z 844 T>A polymorphism within the 3'-UTR of CD3Z confers increased risk of incidence of systemic lupus erythematosus.
    Warchoł T; Piotrowski P; Lianeri M; Cieślak D; Wudarski M; Hrycaj P; Lacki JK; Jagodziński PP
    Tissue Antigens; 2009 Jul; 74(1):68-72. PubMed ID: 19422667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between
    Lee YH; Song GG
    Genet Test Mol Biomarkers; 2023 Sep; 27(9):277-283. PubMed ID: 37695811
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of a functional polymorphism in the 3'-untranslated region of SPI1 with systemic lupus erythematosus.
    Hikami K; Kawasaki A; Ito I; Koga M; Ito S; Hayashi T; Matsumoto I; Tsutsumi A; Kusaoi M; Takasaki Y; Hashimoto H; Arinami T; Sumida T; Tsuchiya N
    Arthritis Rheum; 2011 Mar; 63(3):755-63. PubMed ID: 21360505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
    Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
    Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
    Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
    Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G 3' untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations.
    Lucena-Silva N; de Souza VS; Gomes RG; Fantinatti A; Muniz YC; de Albuquerque RS; Monteiro AL; Diniz GT; Coelho MR; Mendes-Junior CT; Castelli Eda C; Donadi EA
    J Rheumatol; 2013 Jul; 40(7):1104-13. PubMed ID: 23678155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.